Basit öğe kaydını göster

dc.contributor.authorARINCI, A
dc.contributor.authorTOPALAN, M
dc.contributor.authorGUVENC, H
dc.contributor.authorERER, M
dc.date.accessioned2021-03-04T09:39:38Z
dc.date.available2021-03-04T09:39:38Z
dc.date.issued1993
dc.identifier.citationTOPALAN M., ARINCI A., ERER M., GUVENC H., "THE EFFECT OF PARENTERAL PENTOXIFYLLINE THERAPY ON SKIN FLAP SURVIVAL", EUROPEAN JOURNAL OF PLASTIC SURGERY, cilt.16, sa.1, ss.33-35, 1993
dc.identifier.issn0930-343X
dc.identifier.othervv_1032021
dc.identifier.otherav_6947db8e-1b58-44c2-8cbd-88f18e0e6cb0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/72953
dc.identifier.urihttps://doi.org/10.1007/bf00192704
dc.description.abstractThe effect of pentoxifylline as a hemorrheologic agent on skin flap survival has been observed. A caudally pedicled dorsal flap with an ischemic component in rats was used as the model. The flap survival was calculated to be 0.807+/-0.049 in the control group (n = 15), where flap survival was found to be 0.9713+/-0.018 in the pentoxifylline treated group (n = 15) (t = 12.19, p < 0.005). In the meantime, living flap length was measured as 9.96+/-0.72 in the control group, and 11.84+/-0.18 in the pentoxifylline treated group. With these results, we have come to the conclusion that parenteral pentoxifylline therapy is effective on ischemic skin flap survival in the rat model.
dc.language.isoeng
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCERRAHİ
dc.titleTHE EFFECT OF PARENTERAL PENTOXIFYLLINE THERAPY ON SKIN FLAP SURVIVAL
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF PLASTIC SURGERY
dc.contributor.department, ,
dc.identifier.volume16
dc.identifier.issue1
dc.identifier.startpage33
dc.identifier.endpage35
dc.contributor.firstauthorID113961


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster